Innovating Biologics Discovery using the NonaHCAbFx Platform
- The limitations of camelid nanobodies in bispecifics and the advantages of fully human HCAbs from Harbour Mice®.
- A novel function-based screening platform for identifying CD19-targeting HCAbs using a CAR-Jurkat reporter system.
- Discovery of fully human CD19 TCEs with superior cytotoxicity compared to reference molecules.